The CD200R1 microglial inhibitory receptor as a therapeutic target in the MPTP model of Parkinson ’s disease

It is suggested that neuroinflammation, in which activated microglial cells play a relevant role, contributes to the development of Parkinson ’s disease (PD). Consequently, the modulation of microglial activati...

Source: Journal of Neuroinflammation - April 6, 2021 Category: Neurology Authors: Neus Rabaneda-Lombarte, Joan Serratosa, Jordi Bov é, Miquel Vila, Josep Saura and Carme Solà Tags: Research Source Type: research